Document And Entity Information
Document And Entity Information | Oct. 01, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 1, 2021 |
Entity Registrant Name | ZIOPHARM Oncology, Inc. |
Entity Central Index Key | 0001107421 |
Entity Emerging Growth Company | false |
Entity File Number | 001-33038 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 84-1475642 |
Entity Address, Address Line One | One First Avenue |
Entity Address, Address Line Two | Parris Building 34, Navy Yard Plaza |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02129 |
City Area Code | 617 |
Local Phone Number | 259-1970 |
Entity Information, Former Legal or Registered Name | Not Applicable |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | ZIOP |
Security Exchange Name | NASDAQ |